Late-stage melanoma: Experimental drug combo puts 50% of patients into remission
Researchers tested the efficacy of a drug combination for treating stage IV melanoma. They found that 71% of patients responded to the drug combination, and 50% had complete remission. The drug combination is now entering...
Read More